What is the Return on Assets (ROA) of NanoRepro this year?
The Return on Assets (ROA) of NanoRepro is -0.08 undefined this year.
NanoRepro ROA 2025
NanoRepro ROA
-0.08
Ticker
NN6.DE
ISIN
DE0006577109
WKN
657710
In 2025, NanoRepro's return on assets (ROA) was -0.08, a 0% increase from the 0 ROA in the previous year.
NanoRepro Aktienanalyse
What does NanoRepro do?
The Nanorepro AG was founded in 1998 in Marburg an der Lahn and has since developed into a leading company in the development and production of diagnostic rapid tests and self-tests. The company has been listed on the Frankfurt Stock Exchange since 2006 and has its headquarters in the university city of Marburg. Nanorepro's business model focuses on the production and distribution of innovative, reliable, and easy-to-use self-tests for the medical field. The company concentrates on the practical application of the tests - they should be simple, fast, and user-friendly. Nanorepro's core competence lies in the design, production, and distribution of rapid tests and self-tests for the medical field. The company relies on close cooperation with other companies and research institutions to continuously improve the tests and develop new products. Nanorepro focuses on various areas, including the manufacturing of rapid tests and self-tests for the diagnosis of infectious diseases. In addition, the company also offers tests to check pregnancy status or determine ovulation. Nanorepro's range of products also includes self-tests for the early detection of diseases such as diabetes. With its wide range of products, the company is able to address a large customer base and achieve a positive market position. One key product of Nanorepro is the early pregnancy test. This product is easy to handle and allows women to quickly and safely determine if they are pregnant or not. Nanorepro also offers an ovulation test to help women determine the timing of ovulation. Another test offered by the company is the Lyme borreliosis self-test, which allows for the detection of antibodies to Lyme borreliosis. Nanorepro also offers numerous tests for diagnosing infectious diseases. These include tests that can diagnose bacterial or viral infections such as streptococcal infections or hepatitis B and C. The tests are highly accurate and reliable, enabling quick diagnosis and treatment. Another area in which Nanorepro is expanding is the development of self-tests for the early detection of cancer. For this purpose, the company works closely with scientific and research institutions to continuously improve the tests and make them even more precise and reliable. Nanorepro places a strong emphasis on quality control and safety in the production of the tests. The products are CE-certified, ensuring high quality and safety for the user. In addition, the company has been certified according to the standards of the International Quality Management System ISO 13485, guaranteeing a high standard in the production and marketing of medical devices. Overall, Nanorepro AG has established itself as a leading company in the field of rapid tests and self-tests. With its wide range of products and constant willingness to innovate, the company is able to quickly and effectively respond to the requirements of customers and partners. The company's extensive experience in the field of medical diagnostics contributes to Nanorepro being perceived as a reliable partner in medical technology. NanoRepro ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding NanoRepro's Return on Assets (ROA)
NanoRepro's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing NanoRepro's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider NanoRepro's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in NanoRepro’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about NanoRepro stock
What was the ROA of NanoRepro compared to the previous year?
The ROA of NanoRepro has increased by 0% compared to the previous year.
What consequences do high ROA have for investors of NanoRepro?
A high ROA is advantageous for investors of NanoRepro, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in NanoRepro?
A low ROA can be unfavorable for investors of NanoRepro as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of NanoRepro affect the company?
An increase in ROA of NanoRepro can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of NanoRepro impact the company?
A reduction in the ROA of NanoRepro can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of NanoRepro?
Some factors that can influence the ROA of NanoRepro include revenue, operating costs, asset structure, and industry average.
Why is the ROA of NanoRepro important for investors?
The ROA of NanoRepro is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can NanoRepro take to improve ROA?
To improve ROA, NanoRepro can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does NanoRepro pay?
Over the past 12 months, NanoRepro paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 36.9 %. For the coming 12 months, NanoRepro is expected to pay a dividend of 0.5 EUR.
What is the dividend yield of NanoRepro?
The current dividend yield of NanoRepro is 36.9 %.
When does NanoRepro pay dividends?
NanoRepro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of NanoRepro?
NanoRepro paid dividends every year for the past 1 years.
What is the dividend of NanoRepro?
For the upcoming 12 months, dividends amounting to 0.5 EUR are expected. This corresponds to a dividend yield of 36.9 %.
In which sector is NanoRepro located?
NanoRepro is assigned to the 'Health' sector.
Wann musste ich die Aktien von NanoRepro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of NanoRepro from 6/20/2023 amounting to 0.15 EUR, you needed to have the stock in your portfolio before the ex-date on 6/16/2023.
When did NanoRepro pay the last dividend?
The last dividend was paid out on 6/20/2023.
What was the dividend of NanoRepro in the year 2024?
In the year 2024, NanoRepro distributed 0 EUR as dividends.
In which currency does NanoRepro pay out the dividend?
The dividends of NanoRepro are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The NanoRepro stock can be added to a savings plan with the following providers: ING
Andere Kennzahlen von NanoRepro
Our stock analysis for NanoRepro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoRepro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
